Fabricator: Dragon Pharma, Europe
Unit: x1 vial
Strength: 5 mg/ml
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Dragon Pharma Sermorelin 5mg is a synthetic analog of Growth Hormone Releasing Hormone (GHRH 1–29), developed for research focused on the regulation of growth hormone (GH) secretion and pituitary signaling. It is widely studied for its potential to model age-related GH decline and pituitary feedback mechanisms in laboratory settings. For research purposes only.
Full Name: Sermorelin Acetate (GHRH 1–29)
Manufacturer: Dragon Pharma
Product Type: Research peptide
Research Relevance: Investigated for its effects on growth hormone release, pituitary regulation, and endocrine feedback pathways in preclinical research models.
Dragon Pharma Sermorelin acts as a selective agonist at the Growth Hormone Releasing Hormone (GHRH) receptor, stimulating endogenous GH production in experimental models. By binding to these receptors in the anterior pituitary, Sermorelin initiates a cascade involving cAMP activation and GH secretion, offering researchers a reliable tool to study growth hormone physiology and pituitary responsiveness.
In controlled laboratory studies, Dragon Pharma Sermorelin is commonly administered via subcutaneous injection. Standard experimental protocols use 100–300 mcg per injection, 1–2 times daily, depending on study objectives and duration (typically 8–12 weeks). Researchers often evaluate Sermorelin alone or in combination with Ipamorelin or CJC-1295 to observe synergistic effects on GH release and receptor response. For research purposes only.
Reconstitution commonly involves bacteriostatic water to achieve desired study concentrations.
Form: Lyophilized powder for maximum stability.
Conditions:
Short-term: Refrigerate at 2–8°C.
Long-term: Store at -80°C for extended preservation.
Handling: Avoid freeze-thaw cycles; aliquot for experimental use. Protect from light, air, and moisture.
Solution Stability: Use sterile buffers (pH 5–6); store at 4°C for up to 30 days or freeze for longer periods.
For research purposes only. Not for human use or therapeutic applications.
Sermorelin is a synthetic peptide analog of GHRH used in research to study growth hormone regulation, pituitary signaling, and endocrine feedback mechanisms.
Dragon Pharma manufactures Sermorelin 5mg under strict quality and purity standards, ensuring reliable results for laboratory research.
Sermorelin is primarily studied to explore growth hormone secretion, pituitary receptor activity, and age-related declines in GH-axis function in preclinical settings.
In experimental protocols, Sermorelin is typically administered subcutaneously at 100–300 mcg per dose, one to two times daily, depending on the study parameters.
Buy authentic Dragon Pharma Sermorelin 5mg directly from the official supplier Dragon Pharma Peptides for guaranteed research-grade purity and verified laboratory quality.
Please log in to write Sermorelin 5mg review.